Akoya Biosciences Inc (AKYA)
2.86
+0.15
(+5.54%)
USD |
NASDAQ |
Sep 27, 16:00
2.86
0.00 (0.00%)
After-Hours: 20:00
Akoya Biosciences SG&A Expense (TTM): 76.87M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 76.87M |
March 31, 2024 | 81.68M |
December 31, 2023 | 84.94M |
September 30, 2023 | 86.99M |
June 30, 2023 | 87.90M |
March 31, 2023 | 84.58M |
December 31, 2022 | 79.65M |
September 30, 2022 | 77.75M |
Date | Value |
---|---|
June 30, 2022 | 71.55M |
March 31, 2022 | 61.03M |
December 31, 2021 | 51.02M |
September 30, 2021 | 38.79M |
June 30, 2021 | 30.77M |
March 31, 2021 | 25.81M |
December 31, 2020 | 23.98M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
23.98M
Minimum
Dec 2020
87.90M
Maximum
Jun 2023
64.22M
Average
76.87M
Median
Jun 2024
SG&A Expense (TTM) Benchmarks
Bruker Corp | 805.40M |
Azenta Inc | 305.65M |
Harvard Bioscience Inc | 45.99M |
Bionano Genomics Inc | 71.68M |
Singular Genomics Systems Inc | 53.22M |